Monty Allen's most recent trade in Iradimed Corp was a trade of 1,811 Restricted Stock Units done . Disclosure was reported to the exchange on Dec. 11, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Iradimed Corp | Monty Allen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Dec 2024 | 1,811 | 3,008 | - | - | Restricted Stock Units | |
| Iradimed Corp | Monty Allen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2024 | 1,751 | 0 | - | - | Restricted Stock Units | |
| Iradimed Corp | Monty Allen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2024 | 1,751 | 19,804 (0%) | 0% | - | Common Stock | |
| Iradimed Corp | Monty Allen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2024 | 1,196 | 21,000 (0%) | 0% | - | Common Stock | |
| Iradimed Corp | Monty Allen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2024 | 1,196 | 1,197 | - | - | Restricted Stock Units | |
| Iradimed Corp | Monty Allen | Director | Sale of securities on an exchange or to another person at price $ 43.37 per share. | 03 Jun 2024 | 1,947 | 18,053 (0%) | 0% | 43.4 | 84,432 | Common Stock |
| Iradimed Corp | Allen Monty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2023 | 2,393 | 4,144 | - | - | Restricted Stock Units | |
| Iradimed Corp | Monty Allen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2023 | 1,750 | 1,751 | - | - | Restricted Stock Units | |
| Iradimed Corp | Monty Allen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2023 | 1,750 | 20,000 (0%) | 0% | - | Common Stock | |
| Iradimed Corp | Allen Monty | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2023 | 1,036 | 18,250 (0%) | 0% | - | Common Stock | |
| Iradimed Corp | Monty Allen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2023 | 1,036 | 0 | - | - | Restricted Stock Units | |
| Iradimed Corp | Monty Allen | Director | Sale of securities on an exchange or to another person at price $ 46.03 per share. | 10 May 2023 | 2,786 | 17,214 (0%) | 0% | 46.0 | 128,232 | Common Stock |
| Iradimed Corp | Monty Allen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2022 | 3,501 | 4,537 | - | - | Restricted Stock Units | |
| Iradimed Corp | Monty Allen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2022 | 2,037 | 0 | - | - | Restricted Stock Units | |
| Iradimed Corp | Monty Allen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2022 | 2,037 | 18,965 (0%) | 0% | - | Common Stock | |
| Iradimed Corp | Monty Allen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2022 | 1,035 | 1,036 | - | - | Restricted Stock Units | |
| Iradimed Corp | Monty Allen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2022 | 1,035 | 20,000 (0%) | 0% | - | Common Stock | |
| Iradimed Corp | Monty Allen | Director | Sale of securities on an exchange or to another person at price $ 37.71 per share. | 04 Aug 2022 | 3,072 | 16,928 (0%) | 0% | 37.7 | 115,845 | Common Stock |
| Iradimed Corp | Monty Allen | Director | Sale of securities on an exchange or to another person at price $ 47.01 per share. | 24 Feb 2022 | 1,000 | 20,000 (0%) | 0% | 47.0 | 47,014 | Common Stock |
| Iradimed Corp | Monty Allen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2021 | 2,185 | 18,963 (0%) | 0% | - | Common Stock | |
| Iradimed Corp | Monty Allen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2021 | 2,185 | 0 | - | - | Restricted Stock Units | |
| Iradimed Corp | Monty Allen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2021 | 2,071 | 2,071 | - | - | Restricted Stock Units | |
| Iradimed Corp | Monty Allen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2021 | 2,037 | 2,037 | - | - | Restricted Stock Units | |
| Iradimed Corp | Monty Allen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2021 | 2,037 | 21,000 (0%) | 0% | - | Common Stock | |
| Iradimed Corp | Monty Allen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.10 per share. | 03 Aug 2021 | 5,000 | 21,375 (0%) | 0% | 7.1 | 35,500 | Common Stock |
| Iradimed Corp | Monty Allen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2021 | 5,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Iradimed Corp | Monty Allen | Director | Sale of securities on an exchange or to another person at price $ 34.08 per share. | 03 Aug 2021 | 4,597 | 16,778 (0%) | 0% | 34.1 | 156,666 | Common Stock |
| Iradimed Corp | Monty Allen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2020 | 4,074 | 4,074 | - | - | Restricted Stock Units | |
| Iradimed Corp | Monty Allen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2020 | 2,185 | 16,375 (0%) | 0% | - | Common Stock | |
| Iradimed Corp | Monty Allen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2020 | 2,185 | 2,185 | - | - | Restricted Stock Units | |
| Iradimed Corp | Monty Allen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2020 | 1,969 | 14,190 (0%) | 0% | - | Common Stock | |
| Iradimed Corp | Monty Allen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2020 | 1,969 | 0 | - | - | Restricted Stock Units | |
| Iradimed Corp | Monty Allen | Director | Sale of securities on an exchange or to another person at price $ 22.22 per share. | 06 Aug 2020 | 9,062 | 12,221 (0%) | 0% | 22.2 | 201,358 | Common Stock |